| User's Publication |
|
21666
Zhang Z, Aoki H, Umezawa K, Kranrod J, Miyazaki N, Oshima T, Hirao T, Miura Y, Seubert J, Ito K, Aoki S.
Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells.
Cell Death Discov
2024
10(1):166
PubMed ID: 38580661
DOI: 10.1038/s41420-024-01933-4
|
|
21898
Miyazaki K, Ariake K, Sato S, Miura T, Xun J, Douchi D, Ishida M, Ohtsuka H, Mizuma M, Nakagawa K, Kamei T, Unno M.
GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthetic pathway in pancreatic cancer
Clin Exp Metastasis
2024
Jun 18
PubMed ID: 38888874
DOI: 10.1007/s10585-024-10298-y
|
|
18285
Yamakawa K, Koyanagi-Aoi M, Machinaga A, Kakiuchi N, Hirano T, Kodama Y, Aoi T.
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
Cancer Cell Int
2023
23(1):94
PubMed ID: 37198667
DOI: 10.1186/s12935-023-02928-4
|
|
18286
Amada K, Hijiya N, Ikarimoto S, Yanagihara K, Hanada T, Hidano S, Kurogi S, Tsukamoto Y, Nakada C, Kinoshita K, Hirashita Y, Uchida T, Shin T, Yada K, Hirashita T, Kobayashi T, Murakami K, Inomata M, Shirao K, Aoki M, Takekawa M, Moriyama M.
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
Cancer Sci
2023
114(5):2189-2202
PubMed ID: 36694355
DOI: 10.1111/cas.15735
|
|
18288
Kudo Y, Suzuki H, Tanaka T, Kaneko MK, Kato Y.
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas
Antibodies (Basel)
2023
12(2):31
PubMed ID: 37218897
DOI: 10.3390/antib12020031
|
|
22123
Hu Y, Gao P, Xu G, Sun J, Xin W, Kong S, Ding H, Zhu J, Fang L.
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors
Transl Cancer Res
2023
12(4):980-991
PubMed ID: 37180676
DOI: 10.21037/tcr-23-173
|
|
20570
Vaes RDW, van Dijk DPJ, Farshadi EA, Olde Damink SWM, Rensen SS, Langen RC.
Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
J Cachexia Sarcopenia Muscle
2022
PubMed ID: 35146962
DOI: 10.1002/jcsm.12917
|
|
20717
Yamakawa K, Koyanagi-Aoi M, Uehara K, Masuda A, Yanagimoto H, Toyama H, Fukumoto T, Kodama Y, Aoi T.
Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
PLoS One
2022
17(5)
PubMed ID: 35617311
DOI: 10.1371/journal.pone.0266620
|
|
18215
Taniguchi H, Natori Y, Miyagi Y, Hayashi K, Nagamura F, Kataoka K, Imai K.
Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex
Int J Cancer
2021
149(3):646-656
PubMed ID: 33783816
DOI: 10.1002/ijc.33579
|
|
20431
Shiozaki A, Konishi T, Kosuga T, Kudou M, Kurashima K, Inoue H, Shoda K, Arita T, Konishi H, Morimura R, Komatsu S, Ikoma H, Toma A, Kubota T, Fujiwara H, Okamoto K, Otsuji E.
Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells.
Int J Oncol
2021
59(4)
PubMed ID: 34414448
DOI: 10.3892/ijo.2021.5256
|
|
11820
Okazaki J, Tanahashi T, Sato Y, Miyoshi J, Nakagawa T, Kimura T, Miyamoto H, Fujino Y, Nakamura F, Takehara M, Ma B, Bando M, Kitamura S, Okamoto K, Muguruma N, Sogabe M, Takayama T.
MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
Digestion
2020
101(6):794-806
PubMed ID: 31563901
DOI: 10.1159/000503225
|
|
13542
Takehara M, Sato Y, Kimura T, Noda K, Miyamoto H, Fujino Y, Miyoshi J, Nakamura F, Wada H, Bando Y, Ikemoto T, Shimada M, Muguruma N, Takayama T.
Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression
Cancer Sci
2020
111(8):2883-2894
PubMed ID: 32535957
DOI: 10.1111/cas.14527
|
|
14280
Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, Anderson AO, Waters AM, Diehl JN, Papke B, Hodge RG, Klomp JE, Goodwin CM, DeLiberty JM, Wang J, Ng RWS, Gautam P, Bryant KL, Esposito D, Campbell SL, Petricoin EF 3rd, Simanshu DK, Aguirre AJ, Wolpin BM, Wennerberg K, Rudloff U, Cox AD, Der CJ.
Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
Cancer Discov
2020
10(1):104-123
PubMed ID: 31649109
DOI: 10.1158/2159-8290.CD-19-1006
|
|
14803
Kushibiki T, Nakamura T, Tsuda M, Tsuchikawa T, Hontani K, Inoko K, Takahashi M, Asano T, Okamura K, Murakami S, Kurashima Y, Ebihara Y, Noji T, Nakanishi Y, Tanaka K, Maishi N, Sasaki K, Park WR, Shichinohe T, Hida K, Tanaka S, Hirano S.
Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target
Mol Cancer Ther
2020
19(1):187-198
PubMed ID: 31597713
DOI: 10.1158/1535-7163.MCT-19-0491
|
|
11811
Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP.
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.
Cancers (Basel)
2019
11(9):1372
PubMed ID: 31527446
DOI: 10.3390/cancers11091372
|
|
9183
Maria New, Tim Van Acker Jun-Ichi Sakamaki, Ming Jiang, Rebecca E Saunders, Jaclyn Long, Victoria M-Y Wang, Axel Behrens, Joana Cerveira, Padhmanand Sudhakar, Tamas Korcsmaros, Harold B J Jefferies, Kevin M Ryan, Michael Howell, Sharon A Tooze
MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma
Cancer Res
2019
79 (8), 1884-1898
PubMed ID: 30765601
DOI: 10.1158/0008-5472.CAN-18-2553
|
|
10602
Okura R, Fujihara S, Iwama H, Morishita A, Chiyo T, Watanabe M, Hirose K, Kobayashi K, Fujimori T, Kato K, Kamada H, Kobara H, Mori H, Niki T, Hirashima M, Okano K, Suzuki Y, Masaki T.
MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.
Oncol Lett
2018
15:407-414
PubMed ID: 29387226
DOI: 10.3892/ol.2017.7316
|
|
10466
Machihara K, Tanaka H, Hayashi Y, Murakami I, Namba T.
Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
Biochem. Biophys. Res. Commun.
2017
492:33-40
PubMed ID: 28811106
DOI: 10.1016/j.bbrc.2017.08.042
|
|
13746
Moriya C, Taniguchi H, Miyata K, Nishiyama N, Kataoka K, Imai K.
Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice
Carcinogenesis
2017
38(6):638-648
PubMed ID: 28498896
DOI: 10.1093/carcin/bgx040
|
|
14741
Sakamaki JI, Wilkinson S, Hahn M, Tasdemir N, O'Prey J, Clark W, Hedley A, Nixon C, Long JS, New M, Van Acker T, Tooze SA, Lowe SW, Dikic I, Ryan KM.
Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function
Mol Cell
2017
66(4):517-532
PubMed ID: 28525743
DOI: 10.1016/j.molcel.2017.04.027
|
|
9592
Hijiya N, Tsukamoto Y, Nakada C, Tung Nguyen L, Kai T, Matsuura K, Shibata K, Inomata M, Uchida T, Tokunaga A, Amada K, Shirao K, Yamada Y, Mori H, Takeuchi I, Seto M, Aoki M, Takekawa M, Moriyama M.
Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.
Cancer Res.
2016
76:2612-25
PubMed ID: 26941286
DOI: 10.1158/0008-5472.CAN-15-1846
|
|
9735
Ellebaek S, Brix S, Grandal M, Lantto J, Horak ID, Kragh M, Poulsen TT.
Pan-HER-An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand-induced EGFR homo- and heterodimers.
Int. J. Cancer
2016
139:2095-105
PubMed ID: 27342948
DOI: 10.1002/ijc.30242
|
|
12659
Mohammad GH, Olde Damink SW, Malago M, Dhar DK, Pereira SP.
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
PLoS One
2016
11(3):e0151635
PubMed ID: 26989901
DOI: 10.1371/journal.pone.0151635
|
|
7168
Miyamae M, Komatsu S, Ichikawa D, Kawaguchi T, Hirajima S, Okajima W, Ohashi T, Imamura T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E.
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.
Br. J. Cancer
2015
113:1467-76
PubMed ID: 26505678
DOI: 10.1038/bjc.2015.366
|
|
7300
Namba T, Kodama R, Moritomo S, Hoshino T, Mizushima T.
Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.
Cell Death Dis
2015
6:e1795
PubMed ID: 26111057
DOI: 10.1038/cddis.2015.172
|
|
7362
Takeuchi S, Baghdadi M, Tsuchikawa T, Wada H, Nakamura T, Abe H, Nakanishi S, Usui Y, Higuchi K, Takahashi M, Inoko K, Sato S, Takano H, Shichinohe T, Seino K, Hirano S.
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer.
Cancer Res.
2015
75:2629-40
PubMed ID: 25952647
DOI: 10.1158/0008-5472.CAN-14-2921
|
|
5019
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
SU11274 suppresses proliferation and motility of pancreatic cancer cells.
Oncol Lett
2015
10(3):1468-1472
PubMed ID: 26622692
DOI: 10.3892/ol.2015.3452
|
|
15259
Namba T, Kodama R.
Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling
Mar Drugs
2015
13(4):2376-89
PubMed ID: 25894488
DOI: 10.3390/md13042376
|
|
18287
Terashima T, Mizukoshi E, Arai K, Yamashita T, Yoshida M, Ota H, Onishi I, Kayahara M, Ohtsubo K, Kagaya T, Honda M, Kaneko S.
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma
Cancer Immunol Immunother
2014
63(5):479-89
PubMed ID: 24633336
DOI: 10.1007/s00262-014-1529-8
|
|
5018
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
Frizzled-2: A potential novel target for molecular pancreatic cancer therapy.
Oncol Lett
2014
7(1):74-78
PubMed ID: 24348824
DOI: 10.3892/ol.2013.1681
|
|
5024
Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, Konishi H, Takeshita H, Nagata H, Arita T, Hirajima S, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.
Br J Cancer
2013
108(2):361-9
PubMed ID: 23329235
DOI: 10.1038/bjc.2012.546
|
|
3714
Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.
Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
World J Gastroenterol
2013
19(11):1718-27
PubMed ID: 23555160
DOI: 10.3748/wjg.v19.i11.1718
|
|
5020
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
nsulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.
J Cell Biochem
2012
113(8):2714-20
PubMed ID: 22441995
DOI: 10.1002/jcb.24149
|
|
12860
Trono JD, Mizuno K, Yusa N, Matsukawa T, Yokoyama K, Uesaka M.
Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to X-Ray Drug Delivery System
J Radiat Res
2011
52(1):103-9.
PubMed ID: 21187668
DOI: 10.1269/jrr.10068
|
|
8294
Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.
Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.
World J. Gastroenterol.
2010
16:1854-8
PubMed ID: 20397262
DOI: 10.3748/wjg.v16.i15.1854
|
|
6434
K. MIZUNO, M. UESAKA, S. MATSUYAMA, Y. ITO, K. ISHII and H. YAMAZAKI
Evaluation of the uptake of CDDP-containing polymeric micelles in single pancreatic cancer cells
International Journal of PIXE
2010
20:37-43
DOI: 10.1142/S012908351000194X
|
|
8610
Suzuki J, Murakami Y, Samejima K, Ohtani KK, Oka T.
Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells.
Endocr. Relat. Cancer
2009
16:649-59
PubMed ID: 19349429
DOI: 10.1677/ERC-09-0004
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18311
Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A.
Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter
J Nucl Med
2008
49(4):615-22
PubMed ID: 18344442
DOI: 10.2967/jnumed.107.048231
|
Back
Top
CELL BANK Website
